{"disease":{"id":"lambert-eaton-myasthenic-syndrome","name":"lambert eaton myasthenic syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05408702","title":"Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Institut de Myologie, France","has_results":false},{"nct_id":"NCT07478172","title":"Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT06441825","title":"Patient Observation With Environmental and Wearable Sensors in Myasthenia Gravis","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT01825395","title":"Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT02012933","title":"3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT00704925","title":"Treatment of Lambert-Eaton Syndrome With 3,4 DAP","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"David P. Richman, MD","has_results":false},{"nct_id":"NCT00994916","title":"Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"David Lacomis, MD","has_results":false},{"nct_id":"NCT02189720","title":"Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Catalyst Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT00872950","title":"3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Lahey Clinic","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}